Speaker Profile

Ph.D., Chief Scientific Officer, Metabolon

Biography
Dr. Sarangarajan is a recognized R&D leader. As the CSO and SVP Clinical and Translational Sciences at BERG, he led multi-functional teams integrating biology, technology, and artificial intelligence analytics in the development of a multi-omic, biology-based platform for the discovery of disease-specific targets, therapeutic discovery, and diagnostics development. Ranga obtained his Ph.D., in Pharmaceutical Sciences from the University of Cincinnati and a B.S., in Pharmacy from Maharaja Sayajirao University.

Talk
Metabolomics in Drug Development


 Session Abstract – PMWC 2022 Silicon Valley

 Session Abstract – PMWC 2022 Silicon Valley


Track Chair:
Rita Colwell, Johns Hopkins Bloomberg School of Public Health
Manoj Dadlani, CosmosID

Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.

    Sessions:
  • Intro and Overview to Microbiome
    - Rita Colwell, CosmosID
  • Regulatory Perspective
    - Scott Jackson, NIST
  • Metabolomics in Drug Development
    - Rangaprasad Sarangarajan, Metabolon
  • Pharma Drug Development (PANEL)
    Session Chair: Karim Dabbagh, Second Genome
    - Rangaprasad Sarangarajan, Metabolon
  • AI in Microbiome
    - Kaja Milanowska-Zabel, Ardigen
  • Direct-To-Consumer Testing/Technologies (PANEL)
    Session Chair: Nathan D. Price, Thorne HealthTech
    - Kiran Krishnan, Microbiome Labs
    - Nicole Scott, Cybele Microbiome
  • Microbiome and Cancer
    - Sandrine Miller-Montgomery, Micronoma
  • The Role of the Human Gut Microbiome on Various Diseases
    - Colleen Cutcliffe, Pendulum Therapeutics
    - Tor Savidge, Baylor College of Medicine
    - Nikole Kimes, Siolta Therapeutics
    - Sarkis Mazmanian, Caltech
  • The Gut/Brain Microbiome
    - Mary Conrad, Axial Biotherapeutics
    - Christopher Reyes, Bloom Science
  • Showcase
    - Heloise Breton, DNA Genotek
    - Nathan Price, Thorne HealthTech
    - Rita Colwell, CosmosID